Apolipoprotein L-I is the trypanosome lytic factor of human serum
about
Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1Hemoglobin is a co-factor of human trypanosome lytic factorA single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 bindingC-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesienseInitial sequence of the chimpanzee genome and comparison with the human genomeAssociation of trypanolytic ApoL1 variants with kidney disease in African AmericansStructure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunityAPOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyAPOL1 localization in normal kidney and nondiabetic kidney diseaseMissense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneThe apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactionsHydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomesApolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell deathDistinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serumImmune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to PathogenicityHost Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African TrypanosomiasisAPOL1 Kidney Disease Risk Variants: An Evolving LandscapeTrypanosoma cruzi infection and host lipid metabolismKidney disease: new technologies translate mechanisms to cureProteomics investigations of HDL: challenges and promiseTrypanosome resistance to human innate immunity: targeting Achilles' heelAPOL1 kidney risk alleles: population genetics and disease associationsThe biology of APOL1 with insights into the association between APOL1 variants and chronic kidney diseaseGenetic control of resistance to Trypanosoma brucei brucei infection in miceKnockdown of ApoL1 in Zebrafish Larvae Affects the Glomerular Filtration Barrier and the Expression of NephrinStructural basis for trypanosomal haem acquisition and susceptibility to the host innate immune systemAPOL1 toxin, innate immunity, and kidney injuryThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsTrypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistanceIn-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plantsCathepsin-L can resist lysis by human serum in Trypanosoma brucei bruceiTrypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspectsWorldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in AfricaAPOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.Genetic recombination between human and animal parasites creates novel strains of human pathogen.Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host AnemiaIsolation of the repertoire of VSG expression site containing telomeres of Trypanosoma brucei 427 using transformation-associated recombination in yeast.Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.A Gambian infant with fever and an unexpected blood film
P2860
Q21092282-7AF5BA04-C02E-4652-BEBE-24A15E918E4EQ21131604-5F44DD96-146F-4175-AFB5-664C4B8F3FD3Q21558778-202F81CD-6988-4B1B-910C-32D6CE8FF7DCQ21559412-DE6EA721-8F64-4669-9281-21D3621DDCE9Q22122468-5AC0E9A5-DDF9-4724-8426-1C2EB146236DQ24606581-503A6BD0-78C5-42DE-B120-02E297E44436Q24628085-67A74A6C-8F4B-40CF-ADEC-2E018FF6CC2BQ24631837-2D692ADC-0D20-41E6-8688-B1241B90FAC9Q24631960-2A84C2D7-741B-4E3F-83C8-65AF2509F5F1Q24632288-584C18C8-B9D7-4F24-B65B-B791FB5ADE33Q24651930-CD54FD3A-FF95-45F6-833A-9D525F42D199Q24652930-6DD0C733-D163-4927-98B4-FDA845A57047Q24652950-ED483090-BFB2-4CB8-8102-0AEE2A329EA3Q24681132-E7E8D55D-2EF2-4673-807F-E8BED0626BA1Q26742172-0A144A6D-9910-47A7-AD60-D4D7A79D9E2BQ26744647-1C0767F1-6530-4B93-8010-280C0962995AQ26799191-E46B1643-567A-45E4-A39F-97D3694DE652Q26823791-D19E5E8C-3D9D-4BD4-A9E8-224B596197C8Q26825227-7F975950-7463-4BE5-BA1C-ADC223C7E090Q27000995-593EA6F0-5DEE-486E-9480-2E2E18FCCABEQ27006982-D7486C90-C178-4C2C-B507-13F1CE36F39FQ27024261-1D28CC65-B92F-4A66-9F8D-0E62406BDCDFQ27027828-1DEFA02E-3D66-4620-A8E0-EEE092559F4BQ27306175-1AF78C6B-E476-4931-9B31-79CA2737B37BQ27313326-EC6B0342-77FD-4963-94FF-729038331FF9Q27696195-4C30306E-8C7A-4C49-86DC-13E7503D1F82Q28085667-EB9C2A32-973A-400D-A97C-F2F5DAE2B088Q28388695-1BD730CA-AA9C-4F5B-93DF-C77C38168CA6Q28481228-62095B37-5CFA-4B46-BDA3-60E2F5F81E19Q28481512-0553968E-1F62-41BC-B389-E4ABB520B85CQ28538908-9ADD1431-14B3-46F4-B8BF-31197EFD32EDQ28677323-26FEDCCC-8B74-4C53-8DA5-1D157532F50AQ28750412-25222D3E-D36E-4BF4-82CC-CA1630BA4C35Q30279056-F291B95D-BA72-4726-9E9E-5B2EC5D197E8Q30373132-775AF98F-6944-4E82-84AB-F35C4B4BBA42Q30663833-CE62A8DD-5015-4F84-AD89-C936EC1017C5Q30698901-B8FE7F52-B07D-4A4B-9930-08CA3643F61BQ33208595-61C799CF-5E81-4E96-9A03-E06769FC003BQ33220401-25A51066-7613-4DEB-ABA7-147293FD72C3Q33258475-94D7EE13-5B1E-4AD4-B4C3-0CB04FC426B7
P2860
Apolipoprotein L-I is the trypanosome lytic factor of human serum
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@ast
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en-gb
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@nl
type
label
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@ast
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en-gb
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@nl
prefLabel
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@ast
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en-gb
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@nl
P2093
P50
P3181
P356
P1433
P1476
Apolipoprotein L-I is the trypanosome lytic factor of human serum
@en
P2093
Alain Jacquet
Annette Pays
Huang Van Xong
John P Kane
Patricia Tebabi
Robert Brasseur
P2888
P3181
P356
10.1038/NATURE01461
P407
P50
P577
2003-03-06T00:00:00Z
P6179
1051972215